ROYCE & ASSOCIATES LP - ASSERTIO THERAPEUTICS INC ownership

ASSERTIO THERAPEUTICS INC's ticker is ASRT and the CUSIP is 04545L107. A total of 152 filers reported holding ASSERTIO THERAPEUTICS INC in Q4 2018. The put-call ratio across all filers is 0.48 and the average weighting 0.0%.

Quarter-by-quarter ownership
ROYCE & ASSOCIATES LP ownership history of ASSERTIO THERAPEUTICS INC
ValueSharesWeighting
Q1 2020$102,000
-48.0%
156,9320.0%0.00%
-50.0%
Q4 2019$196,000
-2.5%
156,932
-0.1%
0.00%0.0%
Q3 2019$201,000
+570.0%
157,126
+1722.2%
0.00%
Q2 2019$30,000
-18.9%
8,623
+16.8%
0.00%
Q1 2019$37,000
+85.0%
7,381
+34.0%
0.00%
Q4 2018$20,0005,5090.00%
Other shareholders
ASSERTIO THERAPEUTICS INC shareholders Q4 2018
NameSharesValueWeighting ↓
PERKINS CAPITAL MANAGEMENT INC 120,600$416,0000.29%
Matarin Capital Management, LLC 762,489$2,631,0000.19%
DELTEC ASSET MANAGEMENT LLC 204,513$706,0000.16%
GLOBEFLEX CAPITAL L P 213,991$738,0000.15%
TSP Capital Management Group, LLC 88,750$306,0000.14%
Spark Investment Management LLC 512,500$1,768,0000.12%
OXFORD ASSET MANAGEMENT LLP 1,141,332$3,938,0000.08%
ALGERT GLOBAL LLC 66,842$231,0000.08%
CIGNA INVESTMENTS INC /NEW 188,018$645,0000.07%
Connor, Clark & Lunn Investment Management Ltd. 3,103,949$10,709,0000.07%
View complete list of ASSERTIO THERAPEUTICS INC shareholders